Case Study: a mid-size biotech organization accelerates Phase II recruitment by 40% with Zymr's decentralized clinical trial platform

a mid-size biotech organization accelerates Phase II recruitment by 40% with Zymr

The client, a mid-size biotech organization, faced significant delays in its clinical trials due to a reliance on traditional, site-based models. These models created geographic and logistical constraints that slowed patient recruitment and resulted in fragmented, manual data collection processes. To overcome these challenges and adopt a decentralized clinical trial approach, the organization partnered with Zymr for a digital platform solution.

Zymr designed and implemented a tailored decentralized clinical trial platform featuring remote monitoring, eCOA/eConsent tools, and integration with EDC and CTMS systems. This solution provided digital tools for patient engagement and automated key workflows. As a result, Zymr helped the client achieve a 40% increase in trial recruitment within months, alongside significant improvements in data quality and patient retention.